ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 145 filers reported holding ASSERTIO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $404,000 | -73.5% | 323,539 | -72.9% | 0.00% | -70.0% |
| Q3 2019 | $1,527,000 | +471.9% | 1,192,864 | +1439.9% | 0.01% | +400.0% |
| Q2 2019 | $267,000 | -91.6% | 77,466 | -87.7% | 0.00% | -93.3% |
| Q1 2019 | $3,192,000 | +809.4% | 629,629 | +547.5% | 0.03% | +650.0% |
| Q4 2018 | $351,000 | -41.3% | 97,240 | -4.5% | 0.00% | -33.3% |
| Q3 2018 | $598,000 | – | 101,773 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 3,600,316 | $4,500,000 | 0.51% |
| Aristides Capital LLC | 140,625 | $176,000 | 0.14% |
| TSP Capital Management Group, LLC | 248,100 | $310,000 | 0.13% |
| Anson Funds Management LP | 86,767 | $108,000 | 0.12% |
| Factorial Partners, LLC | 97,000 | $122,360,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 267,309 | $334,000 | 0.04% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,113,351 | $1,392,000,000 | 0.04% |
| DELTEC ASSET MANAGEMENT LLC | 145,700 | $182,000 | 0.04% |
| OAKTREE CAPITAL MANAGEMENT LP | 1,492,455 | $1,865,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 930,134 | $1,163,000 | 0.03% |